The WuXi PharmaTech and Mayo Clinic-backed aging disease drug developer floated at the midpoint of its range.

China-based electronics producer Xiaomi has reportedly filed for an initial public offering at a $100bn valuation in Hong Kong.

The sleep apnea developer, backed by Medtronic and Johnson & Johnson, floated at the top of its range before seeing its stock rise 56% on the first day.

SoftBank is set to completely exit Flipkart as part of a deal that will value the company at $20bn, in which Alphabet is now expected to be involved.

Viking Global will take a majority stake in the cosmetics subscription service, once valued at $485m, wiping out other investors including Comcast Ventures.

The Qualcomm and NGP-backed electronics producer is reportedly seeking a $100bn valuation for the Hong Kong offering.

Radius, which is backed by Salesforce, Comcast, BBVA and Amex, has merged with fellow B2B marketing software provider Leadspace.

The corporate-backed pharmaceutical developers had aimed to raise a total of $155m from offerings they filed for in March.

The Kraft Group-backed spinal muscular atrophy drug developer has raised more than $100m in funding since 2012.

The Samsung Ventures-backed laser manufacturing technology developer popped 56% after floating above its range last week.